Kitahara S, Kataoka Y, Nicholls SJ, Funabashi S, et al. Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trial. Atherosclerosis 2025;409:120470.
PMID: 40818165